Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
19-1
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Journals
Journal #577
advertisement
Journal of Ocular Pharmacology and Therapeutics
34
Showing records 1 to 25 |
Display all abstracts in
Journal of Ocular Pharmacology and Therapeutics
74091
Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus
Toris CB
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 501-518
74445
The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Liu X
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 693-703
74615
Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Di Zazzo A
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 670-677
74106
The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies
Cavet ME
Journal of Ocular Pharmacology and Therapeutics
2018; 34: 52-60
74248
Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Trese MGJ
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 591-597
74182
Targets of Neuroprotection in Glaucoma
He S
Journal of Ocular Pharmacology and Therapeutics
2018; 34: 85-106
74165
The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma
Katsanos A
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 598-603
74615
Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Roberti G
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 670-677
74182
Targets of Neuroprotection in Glaucoma
Stankowska DL
Journal of Ocular Pharmacology and Therapeutics
2018; 34: 85-106
74091
Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus
Gelfman C
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 501-518
74106
The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies
DeCory HH
Journal of Ocular Pharmacology and Therapeutics
2018; 34: 52-60
74165
The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma
Dastiridou AI
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 598-603
74248
Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Lewis AW
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 591-597
74445
The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Yang Y; Guo X
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 693-703
74615
Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Mashaghi A
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 670-677
74248
Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Blachley TS
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 591-597
74165
The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma
Quaranta L
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 598-603
74182
Targets of Neuroprotection in Glaucoma
Ellis DZ
Journal of Ocular Pharmacology and Therapeutics
2018; 34: 85-106
74091
Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus
Whitlock A
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 501-518
74182
Targets of Neuroprotection in Glaucoma
Krishnamoorthy RR
Journal of Ocular Pharmacology and Therapeutics
2018; 34: 85-106
74445
The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Liu L
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 693-703
74248
Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Stein JD
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 591-597
74165
The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma
Rulli E
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 598-603
74615
Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Abud TB
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 670-677
74091
Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus
Sponsel WE
Journal of Ocular Pharmacology and Therapeutics
2017; 33: 501-518
«
1
2
»
Issue
19-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement